Find your next paid study

National Cancer Institute (NCI)NCT05436418

~$500 – $6,750

Actual pay is set by the research site.

High-risk Myeloid MalignancyAllogenic Stem Cell TransplantationAcute Myeloid Leukemia (AML)+6 more

UW26119: Maintenance Treatment With Imetelstat in Patients With High-Risk Myeloid Neoplasms After Allogeneic Stem Cell Transplantation

The purpose of this clinical trial is to learn if imetelstat is safe to use in participants with high-risk myeloid malignancies who have received an allogenic …

University of Wisconsin, MadisonNCT07909733

~$150 – $3,000

Actual pay is set by the research site.

Sickle Cell DiseaseHematopoetic Stem Cell TransplantHaploidentical Hematopoietic Stem Cell Transplant+2 more

Ruxolitinib-Enhanced Conditioning for Pediatric and Young Adult Patients With Symptomatic Sickle Cell Disease Undergoing Haploidentical Hematopoietic Cell Transplantation

This trial will determine whether adding ruxolitinib to a reduced intensity conditioning (RIC) regimen reduces the rate of graft failure following haploidentic…

Arkansas Children's Hospital Research InstituteNCT07252050

~$150 – $3,000

Actual pay is set by the research site.

Phase 2

A Phase 2 Study Evaluating the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of Narsoplimab in Pediatric Patients (28 Days to ≤ 18 Years of Age.) With High-Risk Hematopoietic Stem Cell Transplant Thrombotic Microangiopathy

The purpose of this study is to evaluate the safety and efficacy of narsoplimab in pediatric patients with thrombotic microangiopathies (TMA) following hematop…

Thrombotic MicroangiopathiesHematopoietic Stem Cell Transplantation

Omeros CorporationNCT05855083

~$75 – $2,800

Actual pay is set by the research site.

Hematopoietic Stem Cell TransplantationGraft Failure

Emapalumab for the Prevention of Graft Rejection in Hematopoietic Stem Cell Transplant (HSCT) Recipients

The investigators hypothesize that graft rejection after hematopoietic stem cell transplant (HSCT) is primarily driven by interferon gamma, and prophylactic in…

Children's Hospital Medical Center, CincinnatiNCT07244419

~$150 – $2,700

Actual pay is set by the research site.

Phase 2

A Phase II Study of Allogeneic Hematopoietic Stem Cell Transplant for Subjects With VEXAS (Vacuoles, E1 Enzyme, X-linked, Autoinflammatory, Somatic) Syndrome

Background: Allogeneic hematopoietic stem cell transplant involves taking blood stem cells from a donor and giving them to a recipient. The transplants are us…

ImmunodeficiencyHematopoietic Stem Cell Transplantation

National Cancer Institute (NCI)NCT05027945

~$75 – $1,800

Actual pay is set by the research site.

LeukemiaHematopoetic Stem Cell TransplantationDonor Lymphocyte Infusion+3 more

Exercise-induced Adrenergic Receptor Signaling as an Immune Adjuvant for Allogeneic Cell Therapies

This study aims to improve the treatment of blood cancer by using exercise to collect healthier immune cells from donors. Allogeneic adoptive cell therapy is a…

University of ArizonaNCT06643221

~$500 – $7,500

Actual pay is set by the research site.

Phase 2

Risk-ADAPTed Conditioning Regimen for Allogeneic Hematopoietic Stem Cell Transplantation (ADAPT)

This is a prospective, single-arm, phase II study. Patients will be treated with an allogeneic stem cell transplantation (AHSCT) using fludarabine, melphalan a…

Allogeneic Hematopoietic Stem Cell TransplantationAllogeneic Stem Cell TransplantationHematologic Malignancies

University of California, IrvineNCT06028828

~$75 – $2,000

Actual pay is set by the research site.

Stem Cell TransplantHematopoetic Stem Cell TransplantHematopoetic Stem Cell Transplantation

Adapting After Discharge From Allogeneic SCT: Partnering Together; Dyadic Intervention to Improve Patient-Family Caregiver Team-Based Management of the Medical Regimen After Allogeneic Hematopoietic Cell Transplantation

Adherence to the medical regimen after stem cell transplant is challenging for both patients and their family caregivers. The investigators propose a randomize…

University of PittsburghNCT07107165

Actual pay is set by the research site.

CancerPediatric CancerChemotherapy Effect+3 more

Massage Impact on Sleep in Hospitalization for Pediatric Oncology and Stem Cell Transplant Patients

This study aims to determine the impact of massage therapy for pediatric patients receiving intensive chemotherapy or stem cell transplant (SCT).

Children's Hospital of PhiladelphiaNCT06892158

Actual pay is set by the research site.

Hematopoietic Stem Cell TransplantationHematologic Malignancy

αβT Cell/CD19+ B Cell Depletion for Alternative Donor Allogeneic Hematopoietic Cell Transplantation (HSCT) for Children and Young Adults With Hematologic Malignancies

This is a study utilizing the Magnetic-activated cell sorting (CliniMACS®) Alpha-Beta T-cell (αβT)/Cluster of Differentiation 19 (CD19), also called B lymphocy…

Nationwide Children's HospitalNCT06082947

Actual pay is set by the research site.

Hematopoietic Stem Cell TransplantationCardiorespiratory Fitness

Remotely Monitored, Mobile Health-supported, High Intensity Interval Training Before Hematopoietic Stem Cell Transplantation (REMM-HIIT-HCT)

The goal of this clinical trial is to learn how a remotely monitored high-intensity interval training (REMM-HIIT) affects the cardiorespiratory fitness and phy…